SIRT6 Attenuates Angiotensin II-Induced Podocyte Cholesterol Accumulation and Injury via Negative Modulation of SREBP2
Kidney and Blood Pressure Research · 03.07.2026 · 51 (1) · 715-728
DOI: 10.1159/000552307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 03.07.2026. Verfasst von Yingjie Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Angiotensin II, Sterol Regulatory Element Binding Protein 2, Podocytes, Sirtuins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Angiotensin (Ang) II can cause podocyte injury and leads to chronic kidney disease (CKD), but the specific mechanism is not clear. In our previous study, we found that Ang II reduced the expression of cholesterol efflux-associated molecule by regulating sirtuin 6 (SIRT6), thereby inducing podocyte cholesterol accumulation and injury. However, the effect of SIRT6 on podocyte cholesterol synthesis is unclear. In this study, we evaluated the role of SIRT6 in the expression of cholesterol synthesis-associated molecular sterol regulatory element-binding protein 2 (SREBP2), cholesterol content, and apoptosis levels in podocytes.
Methods
Ang II-infused rat model was constructed. Cholesterol quantification was examined using a cholesterol quantitation kit. The expression of SIRT6 and SREBP2 was examined by Western blot and immunofluorescence assay. The podocyte apoptotic level was detected by flow cytometry. Transfection of podocytes with pcDNA3.1 SIRT6 plasmid and the deacetylase-inactive SIRT6 mutant plasmid (pcDNA3.1 SIRT6 H133Y) was performed to investigate whether SIRT6 regulates SREBP2 expression and to further determine if this regulatory effect is dependent on SIRT6’s deacetylase activity.
Results
Ang II promoted lipid droplet and cholesterol accumulation in rat glomeruli, suppressed SIRT6 expression, and enhanced SREBP2 activation, evidenced by increased SREBP2 levels and nuclear translocation. Transfection of pcDNA3.1 SIRT6 into podocytes attenuated SREBP2 activation, reducing Ang II-induced cholesterol accumulation and apoptosis. Experiments using pcDNA3.1 SIRT6 and pcDNA3.1 SIRT6 H133Y plasmids indicate that SIRT6-mediated suppression of SREBP2 requires its histone deacetylase activity.
Conclusion
We conclude that SIRT6 serves as a key protective regulator of podocytes against RAS activation, at least in part by suppressing SREBP2 expression and thereby alleviating cholesterol accumulation and associated podocyte injury. It provides a new target for clinical treatment of CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China, linxu2018@whu.edu.cn.
- Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China, 359515393@qq.com.
Zitieren
APA
Yang, Y., Ma, J., Chang, D., Ma, S., Xu, L., & Dang, J. (2026). SIRT6 Attenuates Angiotensin II-Induced Podocyte Cholesterol Accumulation and Injury via Negative Modulation of SREBP2. Kidney and Blood Pressure Research, 51(1), 715-728. https://doi.org/10.1159/000552307
Vancouver
Yang Y, Ma J, Chang D, Ma S, Xu L, Dang J. SIRT6 Attenuates Angiotensin II-Induced Podocyte Cholesterol Accumulation and Injury via Negative Modulation of SREBP2. Kidney and Blood Pressure Research. 2026;51(1):715-728. doi:10.1159/000552307
BibTeX
@article{Yang2026,
author = {Yang, Yingjie and Ma, Jingjing and Chang, Danqi and Ma, Shijing and Xu, Lin and Dang, Jianzhong},
title = {SIRT6 Attenuates Angiotensin II-Induced Podocyte Cholesterol Accumulation and Injury via Negative Modulation of SREBP2},
journal = {Kidney and Blood Pressure Research},
year = {2026},
volume = {51},
number = {1},
pages = {715--728},
doi = {10.1159/000552307}
}
EUVIMED